Jim Cramer’s Thoughts on These 7 Stocks

5. Viking Therapeutics, Inc. (NASDAQ:VKTX)

Number of Hedge Fund Holders: 41

To a caller’s question about Viking Therapeutics, Inc. (NASDAQ:VKTX), Cramer’s response was:

“Okay, people, people think that even if Lily’s stock can’t go up, why would we want Viking Therapeutics? And a lot of people were in it for a takeover. So far it doesn’t look like that’s materializing, so they’re giving up and they are selling it. I prefer Eli Lilly.”

Viking Therapeutics (NASDAQ:VKTX) is dedicated to developing innovative treatments for metabolic and endocrine diseases, with multiple drug candidates undergoing clinical trials for conditions like non-alcoholic steatohepatitis and type 2 diabetes. Cramer recently discussed the company and said:

“I want you to sell Viking Therapeutics and roll it into Viking Holdings, which is a fantastic cruise line, does not save lives, does not lower your blood pressure… but darn, you’ll have a good time.”

Year-to-date, Viking Therapeutics (NASDAQ:VKTX) stock has declined more than 20% while Cramer’s preferred stock, LLY, has gone up over 4%.